EquiVac Innovator EHV-1/4This page contains information on EquiVac Innovator EHV-1/4 for veterinary use.
The information provided typically includes the following:
- EquiVac Innovator EHV-1/4 Indications
- Warnings and cautions for EquiVac Innovator EHV-1/4
- Direction and dosage information for EquiVac Innovator EHV-1/4
EquiVac Innovator EHV-1/4This treatment applies to the following species:
Equine Rhinopneumonitis Vaccine
For vaccination of healthy horses as an aid in the prevention of equine rhinopneumonitis due to type 1 and 4 viruses.
For Veterinary Use Only
DOSE: Horses, inject one 1 mL dose intramuscularly using aseptic technique. Administer a second 1 mL dose 3 to 4 weeks after the first dose. A 1 mL booster dose should be given annually.
EquiVac Innovator EHV-1/4 Caution
Store in the dark at 2° to 7°C (35° to 45°F). AVOID FREEZING. SHAKE WELL. Use entire contents when first opened. In some instances, transient local reactions may occur at the injection site. Do not vaccinate within 21 days before slaughter. In case of anaphylactoid reaction, administer epinephrine.
Thimerosal, neomycin and polymyxin B added as preservatives.
Zoetis Inc., Kalamazoo, MI 49007
U.S. Vet. License No. 190
NAC No.: 36902832
333 PORTAGE STREET, KALAMAZOO, MI, 49007
|Every effort has been made to ensure the accuracy of the EquiVac Innovator EHV-1/4 information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2017 North American Compendiums. Updated: 2017-02-06